Abstract
The report covers a forecast and an analysis of the protein engineering market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the protein engineering market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the protein engineering market on a global level.
In order to give the users of this report a comprehensive view of the protein engineering market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of the major participants involved in the market on a global and regional basis. Moreover, the study covers the price trend analysis and application portfolio of various companies according to regions.
The study provides a decisive view of the protein engineering market by segmenting it based on product type, technology, protein type, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2024. By product type, the market is segmented into instruments, reagents, and services and software. Based on technology, the global protein engineering market is segmented into rational protein design and irrational protein design. The protein type segment of the global protein engineering market is segmented into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, a coagulation factor, vaccines, and others. Academic research institutes, pharmaceutical, and biotechnology companies, and contract research organizations comprise the end-user segment of the global protein engineering market.
The regional segment of the protein engineering market includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., UK, Germany, France, Italy, Spain, China, Japan, India, Brazil, etc.
Some key players of the global protein engineering market are GE Healthcare, AB-Sciex, Agilent Technologies, Sigma-Aldrich Corp., Bio-Rad Laboratories, Inc., Perkin Elmer, Thermo Fisher Scientific, Bruker Corp., and Waters Corp., among others.
This report segments the global protein engineering market into:
Global Protein Engineering Market: Product Type Analysis
Instruments
Reagents
Services and Software
Global Protein Engineering Market: Technology Analysis
Rational Protein Design
Irrational Protein Design
Global Protein Engineering Market: Protein Type Analysis
Monoclonal Antibodies
Insulin
Erythropoietin
Interferon
Colony Stimulating Factor
Growth Hormones
Coagulation Factor
Vaccines
Others
Global Protein Engineering Market: End-User Analysis
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Global Protein Engineering Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa